Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Depreciation & Amortization (CF): 2013-2020

Historic Depreciation & Amortization (CF) for Larimar Therapeutics (LRMR) over the last 7 years, with Dec 2020 value amounting to $50,000.

  • Larimar Therapeutics' Depreciation & Amortization (CF) rose 150.00% to $50,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $155,000, marking a year-over-year increase of 98.72%. This contributed to the annual value of $318,000 for FY2024, which is 2.25% up from last year.
  • Per Larimar Therapeutics' latest filing, its Depreciation & Amortization (CF) stood at $50,000 for Q4 2020, which was down 0.00% from $50,000 recorded in Q3 2020.
  • In the past 5 years, Larimar Therapeutics' Depreciation & Amortization (CF) registered a high of $107,000 during Q3 2018, and its lowest value of -$13,000 during Q2 2019.
  • For the 3-year period, Larimar Therapeutics' Depreciation & Amortization (CF) averaged around $41,167, with its median value being $50,000 (2020).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first surged by 900.00% in 2016, then slumped by 125.00% in 2019.
  • Larimar Therapeutics' Depreciation & Amortization (CF) (Quarterly) stood at $61,000 in 2016, then decreased by 18.03% to $50,000 in 2017, then increased by 4.00% to $52,000 in 2018, then tumbled by 61.54% to $20,000 in 2019, then soared by 150.00% to $50,000 in 2020.
  • Its Depreciation & Amortization (CF) was $50,000 in Q4 2020, compared to $50,000 in Q3 2020 and $32,000 in Q2 2020.